Co-Diagnostics, Inc. (CODX)
OTCMKTS · Delayed Price · Currency is USD
2.830
-0.090 (-3.08%)
At close: Jan 16, 2026
Co-Diagnostics Employees
Co-Diagnostics had 132 employees as of December 31, 2024. The number of employees decreased by 23 or -14.84% compared to the previous year.
Employees
132
Change (1Y)
-23
Growth (1Y)
-14.84%
Revenue / Employee
$3,848
Profits / Employee
-$243,799
Market Cap
5.74M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 132 | -23 | -14.84% |
| Dec 31, 2023 | 155 | 10 | 6.90% |
| Dec 31, 2022 | 145 | 44 | 43.56% |
| Dec 31, 2021 | 101 | 62 | 158.97% |
| Dec 31, 2020 | 39 | 14 | 56.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Vaxart | 105 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| OpGen | 1 |
Co-Diagnostics News
- 7 days ago - Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships - PRNewsWire
- 20 days ago - Co-Diagnostics announces 1-for-30 reverse stock split - Seeking Alpha
- 20 days ago - Co-Diagnostics Announces Reverse Stock Split - PRNewsWire
- 21 days ago - Co-Diagnostics (CODX) Secures Australian Patent for PCR Platform - GuruFocus
- 21 days ago - Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies - PRNewsWire
- 4 weeks ago - Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India - PRNewsWire
- 4 weeks ago - Co-Diagnostics (CODX) Validates Efficacy of Influenza and COVID-19 Detection Test - GuruFocus
- 4 weeks ago - Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation - PRNewsWire